Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuhan Su

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Medicinal Chemistry|October 10, 2024
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC DegraderLicheng Zhou, Kaijie Zhou, Yu Chang, et al.
Nature Communications|June 4, 2026
An in-sensor communication electronic textile for imperceptible and ultrarobust silent speechYuchen Lin, Shifan Yu, Lei Liu, et al.
Psychiatry Research|March 5, 2023
Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychoticsJingda Cai, Li Li, Tiannan Shao, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Medicinal Chemistry|October 10, 2024
Discovery of ZLC491 as a Potent, Selective, and Orally Bioavailable CDK12/13 PROTAC DegraderLicheng Zhou, Kaijie Zhou, Yu Chang, et al.
Nature Communications|June 4, 2026
An in-sensor communication electronic textile for imperceptible and ultrarobust silent speechYuchen Lin, Shifan Yu, Lei Liu, et al.
Psychiatry Research|March 5, 2023
Relapse in patients with schizophrenia and amisulpride-induced hyperprolactinemia or olanzapine-induced metabolic disturbance after switching to other antipsychoticsJingda Cai, Li Li, Tiannan Shao, et al.
Pageof 5